Life Sciences Tools and Services
Company Overview of Innopsys SA
Innopsys SA develops and markets instruments and associated software for biology laboratories. It offers 2-colour fluorescence scanners for applications, such as HD CGH arrays, HD microarrays, and protein nanoarrays; InnoScan 710 for routine microarray reading; InnoScan 900 for reading current and future high-density microarrays; auto loaders; and Mapix, a data acquisition and analysis software for microarray images. The company offers its products for functional genomics and proteomics applications. The company markets its products through a network of distributors in France and internationally, and through its subsidiary in the United States. Innopsys SA was founded in 1999 and is based in...
Parc d'Activités Activestre
Carbonne, 31 390
Founded in 1999
Key Executives for Innopsys SA
Chief Executive Officer and Financial Director
Sales Director and Executive Director
Compensation as of Fiscal Year 2014.
Innopsys SA Key Developments
Scienion AG and Innopsys SA Agree on Joint Product Offering for Reverse Phase Protein Arrays
Mar 25 13
Scienion AG and Innopsys SA announced cooperation agreement on a seamless integration of its microarray production and detection equipment. Combining technologies of both companies will benefit customers for a broad range of applications. A good example is "reverse phase protein array". RPPA is a high-throughput antibody-based technique developed for functional proteomics studies to evaluate protein activities in biological networks. This is useful in identifying drug selectivity, classifying tumors, predicting responses to target therapies, and many more. Lysates from cultured cells or patient tissue samples are typically deposited and incubated on nitrocellulose membranes. Scienion's sciFLEXARRAYER technology can precisely and gently print lysates on nitrocellulose coated glass slides without damage to the surface. Innopsys InnoScan® 710-IR near infrared scanner is the only product that allows for an IR detection readout of these arrays. It combines a 3µm per pixel resolution with 670 nm and 785 nm excitation lasers, a spectral range where the auto-fluorescence of nitrocellulose that is typically present in the visible range is significantly decreased. This product combination will significantly improve signal to noise ratios. Systems will be offered as full out-of-the-box solutions, where equipment and software have been configured to execute RPPA assays from A to Z. This will lower the barrier of entry, allowing more researchers to experiment with RPPA.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries